The  ||| S:0 E:4 ||| DT
fat-mass  ||| S:4 E:13 ||| JJ
and  ||| S:13 E:17 ||| CC
obesity-associated  ||| S:17 E:36 ||| JJ
gene  ||| S:36 E:41 ||| NN
( ||| S:41 E:42 ||| -LRB-
FTO ||| S:42 E:45 ||| NNP
)  ||| S:45 E:47 ||| -RRB-
predicts  ||| S:47 E:56 ||| VBZ
mortality  ||| S:56 E:66 ||| NN
in  ||| S:66 E:69 ||| IN
chronic  ||| S:69 E:77 ||| JJ
kidney  ||| S:77 E:84 ||| NN
disease  ||| S:84 E:92 ||| NN
of  ||| S:92 E:95 ||| IN
various  ||| S:95 E:103 ||| JJ
severity  ||| S:103 E:112 ||| NN
Polymorphisms  ||| S:112 E:126 ||| NNS
in  ||| S:126 E:129 ||| IN
the  ||| S:129 E:133 ||| DT
FTO  ||| S:133 E:137 ||| NNP
( ||| S:137 E:138 ||| -LRB-
fat-mass  ||| S:138 E:147 ||| NNP
and  ||| S:147 E:151 ||| CC
obesity-associated ||| S:151 E:169 ||| NNP
)  ||| S:169 E:171 ||| -RRB-
gene  ||| S:171 E:176 ||| NN
have  ||| S:176 E:181 ||| VBP
been  ||| S:181 E:186 ||| VBN
associated  ||| S:186 E:197 ||| VBN
with  ||| S:197 E:202 ||| IN
the  ||| S:202 E:206 ||| DT
body  ||| S:206 E:211 ||| NN
mass  ||| S:211 E:216 ||| NN
index ||| S:216 E:221 ||| NN
,  ||| S:221 E:223 ||| ,
cancer ||| S:223 E:229 ||| NN
,  ||| S:229 E:231 ||| ,
type  ||| S:231 E:236 ||| NN
2  ||| S:236 E:238 ||| CD
diabetes  ||| S:238 E:247 ||| NN
and  ||| S:247 E:251 ||| CC
hypertension ||| S:251 E:263 ||| NN
.  ||| S:263 E:265 ||| .
We  ||| S:265 E:268 ||| PRP
investigated  ||| S:268 E:281 ||| VBD
the  ||| S:281 E:285 ||| DT
relationship  ||| S:285 E:298 ||| NN
between  ||| S:298 E:306 ||| IN
17  ||| S:306 E:309 ||| CD
tag  ||| S:309 E:313 ||| NN
single-nucleotide  ||| S:313 E:331 ||| JJ
polymorphisms  ||| S:331 E:345 ||| NNS
( ||| S:345 E:346 ||| -LRB-
SNPs ||| S:346 E:350 ||| NNP
)  ||| S:350 E:352 ||| -RRB-
and  ||| S:352 E:356 ||| CC
all-cause  ||| S:356 E:366 ||| JJ
mortality  ||| S:366 E:376 ||| NN
in  ||| S:376 E:379 ||| IN
three  ||| S:379 E:385 ||| CD
cohorts  ||| S:385 E:393 ||| NNS
of  ||| S:393 E:396 ||| IN
dialysis  ||| S:396 E:405 ||| NN
patients  ||| S:405 E:414 ||| NNS
( ||| S:414 E:415 ||| -LRB-
CREED-1 ||| S:415 E:422 ||| NNP
,  ||| S:422 E:424 ||| ,
North  ||| S:424 E:430 ||| NNP
Apulian  ||| S:430 E:438 ||| NNP
and  ||| S:438 E:442 ||| CC
CREED-2  ||| S:442 E:450 ||| CD
cohorts ||| S:450 E:457 ||| NNS
;  ||| S:457 E:459 ||| :
n  ||| S:459 E:461 ||| CD
=  ||| S:461 E:463 ||| SYM
783 ||| S:463 E:466 ||| CD
)  ||| S:466 E:468 ||| -RRB-
and  ||| S:468 E:472 ||| CC
in  ||| S:472 E:475 ||| IN
one  ||| S:475 E:479 ||| CD
cohort  ||| S:479 E:486 ||| NN
of  ||| S:486 E:489 ||| IN
stage  ||| S:489 E:495 ||| NN
2-5  ||| S:495 E:499 ||| NNP
CKD  ||| S:499 E:503 ||| NNP
patients  ||| S:503 E:512 ||| NNS
( ||| S:512 E:513 ||| -LRB-
n  ||| S:513 E:515 ||| CD
=  ||| S:515 E:517 ||| SYM
757 ||| S:517 E:520 ||| CD
) ||| S:520 E:521 ||| -RRB-
.  ||| S:521 E:523 ||| .
We  ||| S:523 E:526 ||| PRP
first  ||| S:526 E:532 ||| RB
explored  ||| S:532 E:541 ||| VB
the  ||| S:541 E:545 ||| DT
association  ||| S:545 E:557 ||| NN
between  ||| S:557 E:565 ||| IN
the  ||| S:565 E:569 ||| DT
17  ||| S:569 E:572 ||| CD
tag  ||| S:572 E:576 ||| NN
SNPs  ||| S:576 E:581 ||| NN
and  ||| S:581 E:585 ||| CC
all-cause  ||| S:585 E:595 ||| JJ
mortality  ||| S:595 E:605 ||| NN
in  ||| S:605 E:608 ||| IN
the  ||| S:608 E:612 ||| DT
CREED-1  ||| S:612 E:620 ||| CD
cohort  ||| S:620 E:627 ||| NNS
and  ||| S:627 E:631 ||| CC
found  ||| S:631 E:637 ||| VBD
that  ||| S:637 E:642 ||| IN
patients  ||| S:642 E:651 ||| NNS
with  ||| S:651 E:656 ||| IN
the  ||| S:656 E:660 ||| DT
A  ||| S:660 E:662 ||| DT
allele  ||| S:662 E:669 ||| NN
of  ||| S:669 E:672 ||| IN
the  ||| S:672 E:676 ||| DT
FTO  ||| S:676 E:680 ||| NNP
rs708259  ||| S:680 E:689 ||| NNP
polymorphism  ||| S:689 E:702 ||| NN
had  ||| S:702 E:706 ||| VBD
an  ||| S:706 E:709 ||| DT
elevated  ||| S:709 E:718 ||| JJ
risk  ||| S:718 E:723 ||| NN
of  ||| S:723 E:726 ||| IN
mortality  ||| S:726 E:736 ||| NN
( ||| S:736 E:737 ||| -LRB-
hazard  ||| S:737 E:744 ||| NN
ratio ||| S:744 E:749 ||| NN
,  ||| S:749 E:751 ||| ,
HR ||| S:751 E:753 ||| NNP
:  ||| S:753 E:755 ||| :
1.52 ||| S:755 E:759 ||| CD
,  ||| S:759 E:761 ||| ,
95 ||| S:761 E:763 ||| CD
%  ||| S:763 E:765 ||| NN
confidence  ||| S:765 E:776 ||| NN
interval  ||| S:776 E:785 ||| NNS
( ||| S:785 E:786 ||| -LRB-
CI ||| S:786 E:788 ||| NNP
)  ||| S:788 E:790 ||| -RRB-
1.11-2.08 ||| S:790 E:799 ||| SYM
;  ||| S:799 E:801 ||| :
P  ||| S:801 E:803 ||| NN
=  ||| S:803 E:805 ||| SYM
0.008 ||| S:805 E:810 ||| CD
) ||| S:810 E:811 ||| -RRB-
.  ||| S:811 E:813 ||| .
Similarly ||| S:813 E:822 ||| RB
,  ||| S:822 E:824 ||| ,
the  ||| S:824 E:828 ||| DT
A  ||| S:828 E:830 ||| DT
allele  ||| S:830 E:837 ||| NN
was  ||| S:837 E:841 ||| VBD
associated  ||| S:841 E:852 ||| VBN
with  ||| S:852 E:857 ||| IN
an  ||| S:857 E:860 ||| DT
increased  ||| S:860 E:870 ||| JJ
risk  ||| S:870 E:875 ||| NN
of  ||| S:875 E:878 ||| IN
death  ||| S:878 E:884 ||| NN
also  ||| S:884 E:889 ||| RB
in  ||| S:889 E:892 ||| IN
the  ||| S:892 E:896 ||| DT
other  ||| S:896 E:902 ||| JJ
two  ||| S:902 E:906 ||| CD
dialysis  ||| S:906 E:915 ||| NN
cohorts  ||| S:915 E:923 ||| NNS
( ||| S:923 E:924 ||| -LRB-
North  ||| S:924 E:930 ||| NNP
Apulian  ||| S:930 E:938 ||| NNP
cohort ||| S:938 E:944 ||| NN
,  ||| S:944 E:946 ||| ,
risk ||| S:946 E:950 ||| NN
:  ||| S:950 E:952 ||| :
+23 ||| S:952 E:955 ||| CD
% ||| S:955 E:956 ||| NN
;  ||| S:956 E:958 ||| :
CREED-2  ||| S:958 E:966 ||| CD
cohort ||| S:966 E:972 ||| NN
,  ||| S:972 E:974 ||| ,
risk ||| S:974 E:978 ||| NN
:  ||| S:978 E:980 ||| :
+21 ||| S:980 E:983 ||| CD
% ||| S:983 E:984 ||| NN
) ||| S:984 E:985 ||| -RRB-
.  ||| S:985 E:987 ||| .
The  ||| S:987 E:991 ||| DT
elevated  ||| S:991 E:1000 ||| JJ
risk  ||| S:1000 E:1005 ||| NN
portended  ||| S:1005 E:1015 ||| NN
by  ||| S:1015 E:1018 ||| IN
this  ||| S:1018 E:1023 ||| DT
allele  ||| S:1023 E:1030 ||| NN
was  ||| S:1030 E:1034 ||| VBD
even  ||| S:1034 E:1039 ||| RB
higher  ||| S:1039 E:1046 ||| JJR
in  ||| S:1046 E:1049 ||| IN
the  ||| S:1049 E:1053 ||| DT
stage  ||| S:1053 E:1059 ||| NN
2-5  ||| S:1059 E:1063 ||| FW
CKD  ||| S:1063 E:1067 ||| FW
cohort  ||| S:1067 E:1074 ||| FW
( ||| S:1074 E:1075 ||| -LRB-
+97 ||| S:1075 E:1078 ||| NNP
% ||| S:1078 E:1079 ||| NN
) ||| S:1079 E:1080 ||| -RRB-
.  ||| S:1080 E:1082 ||| .
However ||| S:1082 E:1089 ||| RB
,  ||| S:1089 E:1091 ||| ,
the  ||| S:1091 E:1095 ||| DT
risk  ||| S:1095 E:1100 ||| NN
of  ||| S:1100 E:1103 ||| IN
mortality  ||| S:1103 E:1113 ||| NN
associated  ||| S:1113 E:1124 ||| VBN
with  ||| S:1124 E:1129 ||| IN
the  ||| S:1129 E:1133 ||| DT
A  ||| S:1133 E:1135 ||| DT
allele  ||| S:1135 E:1142 ||| NN
in  ||| S:1142 E:1145 ||| IN
the  ||| S:1145 E:1149 ||| DT
three  ||| S:1149 E:1155 ||| CD
confirmatory  ||| S:1155 E:1168 ||| NNS
cohorts  ||| S:1168 E:1176 ||| VBP
failed  ||| S:1176 E:1183 ||| VBN
to  ||| S:1183 E:1186 ||| TO
achieve  ||| S:1186 E:1194 ||| VB
formal  ||| S:1194 E:1201 ||| JJ
statistical  ||| S:1201 E:1213 ||| JJ
significance ||| S:1213 E:1225 ||| NN
.  ||| S:1225 E:1227 ||| .
In  ||| S:1227 E:1230 ||| IN
a  ||| S:1230 E:1232 ||| DT
meta-analysis  ||| S:1232 E:1246 ||| JJ
including  ||| S:1246 E:1256 ||| VBG
the  ||| S:1256 E:1260 ||| DT
four  ||| S:1260 E:1265 ||| CD
cohorts  ||| S:1265 E:1273 ||| NNS
( ||| S:1273 E:1274 ||| -LRB-
n  ||| S:1274 E:1276 ||| CD
=  ||| S:1276 E:1278 ||| SYM
1540 ||| S:1278 E:1282 ||| CD
;  ||| S:1282 E:1284 ||| :
total  ||| S:1284 E:1290 ||| JJ
deaths ||| S:1290 E:1296 ||| NNS
,  ||| S:1296 E:1298 ||| ,
n  ||| S:1298 E:1300 ||| VBG
=  ||| S:1300 E:1302 ||| SYM
381 ||| S:1302 E:1305 ||| CD
) ||| S:1305 E:1306 ||| -RRB-
,  ||| S:1306 E:1308 ||| ,
individuals  ||| S:1308 E:1320 ||| NNS
with  ||| S:1320 E:1325 ||| IN
the  ||| S:1325 E:1329 ||| DT
A  ||| S:1329 E:1331 ||| DT
allele  ||| S:1331 E:1338 ||| NN
had  ||| S:1338 E:1342 ||| VBD
a  ||| S:1342 E:1344 ||| DT
42 ||| S:1344 E:1346 ||| CD
%  ||| S:1346 E:1348 ||| NN
excess  ||| S:1348 E:1355 ||| JJ
risk  ||| S:1355 E:1360 ||| NN
of  ||| S:1360 E:1363 ||| IN
death  ||| S:1363 E:1369 ||| NN
( ||| S:1369 E:1370 ||| -LRB-
HR ||| S:1370 E:1372 ||| NNP
:  ||| S:1372 E:1374 ||| :
1.42 ||| S:1374 E:1378 ||| CD
,  ||| S:1378 E:1380 ||| ,
95 ||| S:1380 E:1382 ||| CD
%  ||| S:1382 E:1384 ||| NN
CI  ||| S:1384 E:1387 ||| NNP
1.14-1.76 ||| S:1387 E:1396 ||| NNP
,  ||| S:1396 E:1398 ||| ,
P  ||| S:1398 E:1400 ||| NN
=  ||| S:1400 E:1402 ||| SYM
0.002 ||| S:1402 E:1407 ||| CD
) ||| S:1407 E:1408 ||| -RRB-
.  ||| S:1408 E:1410 ||| .
The  ||| S:1410 E:1414 ||| DT
A  ||| S:1414 E:1416 ||| DT
allele  ||| S:1416 E:1423 ||| NN
of  ||| S:1423 E:1426 ||| IN
the  ||| S:1426 E:1430 ||| DT
FTO  ||| S:1430 E:1434 ||| NNP
rs708259  ||| S:1434 E:1443 ||| NNP
polymorphism  ||| S:1443 E:1456 ||| NN
is  ||| S:1456 E:1459 ||| VBZ
an  ||| S:1459 E:1462 ||| DT
independent  ||| S:1462 E:1474 ||| JJ
predictor  ||| S:1474 E:1484 ||| NN
of  ||| S:1484 E:1487 ||| IN
all-cause  ||| S:1487 E:1497 ||| JJ
mortality  ||| S:1497 E:1507 ||| NN
in  ||| S:1507 E:1510 ||| IN
patients  ||| S:1510 E:1519 ||| NNS
with  ||| S:1519 E:1524 ||| IN
CKD  ||| S:1524 E:1528 ||| NNP
of  ||| S:1528 E:1531 ||| IN
various  ||| S:1531 E:1539 ||| JJ
severity ||| S:1539 E:1547 ||| NN
.  ||| S:1547 E:1549 ||| .
These  ||| S:1549 E:1555 ||| DT
data  ||| S:1555 E:1560 ||| NNS
support  ||| S:1560 E:1568 ||| VBP
our  ||| S:1568 E:1572 ||| PRP$
hypothesis  ||| S:1572 E:1583 ||| NN
that  ||| S:1583 E:1588 ||| IN
the  ||| S:1588 E:1592 ||| DT
FTO  ||| S:1592 E:1596 ||| NNP
gene  ||| S:1596 E:1601 ||| NN
may  ||| S:1601 E:1605 ||| MD
be  ||| S:1605 E:1608 ||| VB
a  ||| S:1608 E:1610 ||| DT
relevant  ||| S:1610 E:1619 ||| JJ
genetic  ||| S:1619 E:1627 ||| JJ
risk  ||| S:1627 E:1632 ||| NN
factor  ||| S:1632 E:1639 ||| NN
for  ||| S:1639 E:1643 ||| IN
mortality  ||| S:1643 E:1653 ||| NN
in  ||| S:1653 E:1656 ||| IN
this  ||| S:1656 E:1661 ||| DT
population ||| S:1661 E:1671 ||| NN
.  ||| S:1671 E:1673 ||| .
